119 related articles for article (PubMed ID: 16030107)
21. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
Okamoto A; Nikaido T; Ochiai K; Takakura S; Saito M; Aoki Y; Ishii N; Yanaihara N; Yamada K; Takikawa O; Kawaguchi R; Isonishi S; Tanaka T; Urashima M
Clin Cancer Res; 2005 Aug; 11(16):6030-9. PubMed ID: 16115948
[TBL] [Abstract][Full Text] [Related]
22. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.
Yuan Y; Nymoen DA; Dong HP; Bjørang O; Shih IeM; Low PS; Trope' CG; Davidson B
Hum Pathol; 2009 Oct; 40(10):1453-60. PubMed ID: 19454358
[TBL] [Abstract][Full Text] [Related]
23. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of SLC34A2 expression in different types of ovarian tumors.
Shyian M; Gryshkova V; Kostianets O; Gorshkov V; Gogolev Y; Goncharuk I; Nespryadko S; Vorobjova L; Filonenko V; Kiyamova R
Exp Oncol; 2011 Jun; 33(2):94-8. PubMed ID: 21716206
[TBL] [Abstract][Full Text] [Related]
25. Serial analysis of gene expression (SAGE): application in cancer research.
Tuteja R; Tuteja N
Med Sci Monit; 2004 Jun; 10(6):RA132-40. PubMed ID: 15173683
[TBL] [Abstract][Full Text] [Related]
26. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
27. Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.
Zorn KK; Jazaeri AA; Awtrey CS; Gardner GJ; Mok SC; Boyd J; Birrer MJ
Clin Cancer Res; 2003 Oct; 9(13):4811-8. PubMed ID: 14581352
[TBL] [Abstract][Full Text] [Related]
28. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
[TBL] [Abstract][Full Text] [Related]
29. Analysis of gene expression profile in colon cancer using the Cancer Genome Anatomy Project and RNA interference.
Huang ZG; Ran ZH; Lu W; Xiao SD
Chin J Dig Dis; 2006; 7(2):97-102. PubMed ID: 16643337
[TBL] [Abstract][Full Text] [Related]
30. Gene expression in epithelial ovarian carcinoma.
Matei D; Graeber TG; Baldwin RL; Karlan BY; Rao J; Chang DD
Oncogene; 2002 Sep; 21(41):6289-98. PubMed ID: 12214269
[TBL] [Abstract][Full Text] [Related]
31. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
[TBL] [Abstract][Full Text] [Related]
33. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
[TBL] [Abstract][Full Text] [Related]
34. Screening for genes associated with ovarian cancer prognosis.
Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H
Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465
[TBL] [Abstract][Full Text] [Related]
35. Identifying tumor origin using a gene expression-based classification map.
Buckhaults P; Zhang Z; Chen YC; Wang TL; St Croix B; Saha S; Bardelli A; Morin PJ; Polyak K; Hruban RH; Velculescu VE; Shih IeM
Cancer Res; 2003 Jul; 63(14):4144-9. PubMed ID: 12874019
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target.
Fejzo MS; Dering J; Ginther C; Anderson L; Ramos L; Walsh C; Karlan B; Slamon DJ
Genes Chromosomes Cancer; 2008 Oct; 47(10):873-83. PubMed ID: 18615678
[TBL] [Abstract][Full Text] [Related]
37. Identification of suitable reference genes for gene expression studies of human serous ovarian cancer by real-time polymerase chain reaction.
Li YL; Ye F; Hu Y; Lu WG; Xie X
Anal Biochem; 2009 Nov; 394(1):110-6. PubMed ID: 19622337
[TBL] [Abstract][Full Text] [Related]
38. 15-Lipoxygenase-2 is differentially expressed in normal and neoplastic ovary.
Roffeis J; Hornung D; Kuhn H; Walther M
Eur J Cancer Prev; 2007 Dec; 16(6):568-75. PubMed ID: 18090132
[TBL] [Abstract][Full Text] [Related]
39. Identification from public data of molecular markers of adenocarcinoma characteristic of the site of origin.
Dennis JL; Vass JK; Wit EC; Keith WN; Oien KA
Cancer Res; 2002 Nov; 62(21):5999-6005. PubMed ID: 12414618
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer.
Tokunaga H; Takebayashi Y; Utsunomiya H; Akahira J; Higashimoto M; Mashiko M; Ito K; Niikura H; Takenoshita S; Yaegashi N
Acta Obstet Gynecol Scand; 2008; 87(10):1060-70. PubMed ID: 18720043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]